Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study will assess the hemodynamic effect of RLX030 infusion in subjects with acute heart
failure. In addition safety and effects on renal function and biomarkers will be assessed.